Abstract
AbstractAntimicrobial resistance (AMR) to all antibiotic classes has been found in the pathogenStaphylococcus aureus. The reported prevalence of these resistances vary, driven by within-host AMR evolution at the patient level, and between-host transmission at the hospital level. Without dense longitudinal sampling, pragmatic analysis of AMR dynamics at multiple levels using routine surveillance data is essential to inform control measures.We exploredS. aureusAMR diversity in 70,000 isolates from a UK paediatric hospital between 2000-2020, using electronic datasets containing multiple routinely collected isolates per patient with phenotypic antibiograms, hospitalisation information, and antibiotic consumption.At the hospital-level, the proportion of isolates that were meticillin-resistant (MRSA) increased between 2014-2020 from 25 to 50%, before sharply decreasing to 30%, likely due to a change in inpatient demographics. Temporal trends in the proportion of isolates resistant to different antibiotics were often correlated in MRSA, but independent in meticillin-susceptibleS. aureus. Ciprofloxacin resistance in MRSA decreased from 70% to 40% of tested isolates between 2007-2020, likely linked to a national policy to reduce fluoroquinolone usage in 2007. At the patient level, we identified frequent AMR diversity, with 4% of patients ever positive forS. aureussimultaneously carrying, at some point, multiple isolates with different resistances. We detected changes over time in AMR diversity in 3% of patients ever positive forS. aureus. These changes equally represented gain and loss of resistance.Within this routinely collected dataset, we found that 65% of changes in resistance within a patient’sS. aureuspopulation could not be explained by antibiotic exposure or between-patient transmission of bacteria, suggesting that within-host evolution via frequent gain and loss of AMR genes may be responsible for these changing AMR profiles. Our study highlights the value of exploring existing routine surveillance data to determine underlying mechanisms of AMR. These insights may substantially improve our understanding of the importance of antibiotic exposure variation, and the success of singleS. aureusclones.
Publisher
Cold Spring Harbor Laboratory
Reference65 articles.
1. World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015. Available: https://apps.who.int/iris/handle/10665/193736
2. Into the storm: Chasing the opportunistic pathogenStaphylococcus aureusfrom skin colonisation to life-threatening infections
3. Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study
4. UK Health Security Agency. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) - Report 2021 to 2022. 2022 Nov p. 181. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1118310/ESPAUR-report-2021-to-2022.pdf
5. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019